Cite
Lipidic profiles of patients starting peritoneal dialysis suggest an increased cardiovascular risk beyond classical dyslipidemia biomarkers.
MLA
Lluesa, Julia Hernández, et al. “Lipidic Profiles of Patients Starting Peritoneal Dialysis Suggest an Increased Cardiovascular Risk beyond Classical Dyslipidemia Biomarkers.” Scientific Reports, vol. 11, no. 1, Sept. 2022, pp. 1–9. EBSCOhost, https://doi.org/10.1038/s41598-022-20757-9.
APA
Lluesa, J. H., López-Romero, L. C., Monzó, J. J. B., Marugán, M. R., Boyano, I. V., Rodríguez-Espinosa, D., Gómez-Bori, A., Orient, A. S., Such, R. D., Perez, P. S., & Jaras, J. H. (2022). Lipidic profiles of patients starting peritoneal dialysis suggest an increased cardiovascular risk beyond classical dyslipidemia biomarkers. Scientific Reports, 11(1), 1–9. https://doi.org/10.1038/s41598-022-20757-9
Chicago
Lluesa, Julia Hernández, Luis Carlos López-Romero, José Jesús Broseta Monzó, Marta Roca Marugán, Iris Viejo Boyano, Diana Rodríguez-Espinosa, Aina Gómez-Bori, et al. 2022. “Lipidic Profiles of Patients Starting Peritoneal Dialysis Suggest an Increased Cardiovascular Risk beyond Classical Dyslipidemia Biomarkers.” Scientific Reports 11 (1): 1–9. doi:10.1038/s41598-022-20757-9.